28.04.2023 • News

Ginkgo and Visolis Work on Bio-based Isoprene

Ginkgo Bioworks is partnering with US startup Visolis to improve the latter’s biomanufacturing process for isoprene and sustainable aviation fuel (SAF).

© Ginkgo
© Ginkgo

Isoprene is a key monomer used in the production of synthetic rubber. Ginkgo said achieving the production of bio-based isoprene at scale “represents a significant step toward decarbonizing tire manufacturing.” The monomer is also used as an intermediate for making high-performance, lower-carbon SAF.

Under the collaboration, Ginkgo aims to use its “extensive” capabilities in strain engineering to improve upon one of Visolis’ existing microbial strains, while also working together to further optimize process efficiency.

According to Ginkgo, Visolis’ production efforts are geared towards providing molecules with higher energy density, lower viscosity and better compatibility with engines than traditional SAF processes. It said Visolis’ SAF has potential to work synergistically with these other processes to enable 100% sustainable fuel for aviation.

Photo

“As we strive to continue improving our technology towards commercial readiness, partnering with Ginkgo to accelerate our progress just makes sense. With their large codebase of strains and pathway expertise, which can shorten strain engineering cycles, as well as their scalable foundry capabilities, we believe we can work towards bringing our process to the next level,” commented Visolis founder and CEO Deepak Dugar.

Earlier this month, Ginkgo entered into a research partnership with Syngenta Seeds. Ginkgo will apply its protein engineering capabilities and proprietary ultra-high throughput screening technologies to complement and accelerate Syngenta’s efforts to design and develop innovative plant traits.

Author: Elaine Burridge, Freelance Journalist

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.